About the Coalition
Thursday, September 27th, 2012
African Americans, Hispanics, and other ethnic minority groups suffer disproportionately from type 2 diabetes and its complications as compared to white Americans. Factors contributing to the ethnic disparities in diabetes and its complications may be inherent (e.g., genetic, cultural, and language/communication) or acquired (e.g., those associated with changes in lifestyle and socioeconomic factors). In many […]
News
Thursday, September 27th, 2012
Laredosun.us: September 22, 2012 Healthy Living/Viviendo Mejor (HLVM) is a disease self management and family support program of the City of Laredo Health Department (CLHD) that has made a difference in diabetes disease self management by focusing on diabetes prevention. Saturday, September 22, 2012 By: Special to The Laredo Sun LAREDO, TEXAS — “We have conducted four cycles […]
News
Thursday, September 27th, 2012
Huffingtonpost.com: 09/20/2012 On July 16th, 2012, n4a Diabetes Care Center received $100,000 as the winner of the 2012 Data Design Diabetes™ Innovation Challenge. The challenge, in its second year and sponsored by Sanofi US, encourages innovation in addressing diabetes. Several dozen startups applied for the challenge with five finalists, including n4a, receiving $20,000 each. n4a Diabetes Care […]
News
Thursday, September 27th, 2012
Diabetes Care: September 17, 2012 This study was designed to examine whether residents living in neighborhoods that are less conducive to walking or other physical activities are more likely to develop diabetes and, if so, whether recent immigrants are particularly susceptible to such effects. METHODS We conducted a population-based, retrospective cohort study to assess the impact of […]
News
Thursday, September 27th, 2012
Onlinelibrary.wiley.com: SEP 3, 2012 Although several epidemiological studies have investigated the relationship between type 2 diabetes mellitus (T2DM) and hip circumference or height, the results are inconsistent. The present systematic review and meta-analysis of published observational studies was conducted to assess the effects of hip circumference and height on diabetes risk. Online databases were searched through […]
News
Thursday, September 27th, 2012
Results from the NHANES 2001–2006 Diabetes Care: October 26, 2012 OBJECTIVE The possible interaction of serum 25-hydroxyvitamin D [25(OH)D] and obesity in regard to type 2 diabetes and insulin resistance has not been well studied. To explore the effect modification of obesity on the association between 25(OH)D and insulin resistance/type 2 diabetes, data were examined from a […]
News
Thursday, September 27th, 2012
Wakehealth.edu: 9/19/12 WINSTON-SALEM, N.C. – Sept. 19, 2012 – A genetic mutation that occurred thousands of years ago might be the answer to how early humans were able to move from central Africa and across the continent in what has been called “the great expansion,” according to new research from Wake Forest Baptist Medical Center. By analyzing genetic […]
Minority Diabetes Reports
Thursday, September 27th, 2012
Oxford Journals: August 28, 2012 American Indians and Alaska Natives (AI/ANs) experience some of the greatest health inequities of any group within the United States. AI/ANs are diagnosed with diabetes more than twice as often as non-Hispanic white Americans. Diabetes is a chronic preventable disease often associated with individual risk factors and behaviors that indicate what […]
Clinical Trial News
Wednesday, September 26th, 2012
Trialsjournal.com: September 24, 2012 Recent evidence has highlighted deficiencies in clinical trial protocols, having implications for many groups. Existing guidelines for randomized clinical trial (RCT) protocol content vary substantially and most do not describe systematic methodology for their development. As one of three prespecified steps for the systematic development of a guideline for trial protocol content, […]
Clinical Trial News
Wednesday, September 26th, 2012
Trialsjournal.com: Jonathan Kimmelman, September 2012 Clinical development of novel therapeutics begins with a coordinated sequence of early phase clinical trials. Such early human studies confront a series of methodological and ethical challenges. In what follows, I propose a theoretical framework for early human studies aimed at informing the negotiation of these challenges. At the outset of clinical […]
